HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J M Herbert Selected Research

Neuropilin-1

6/2001Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J M Herbert Research Topics

Disease

9Thrombosis (Thrombus)
09/2014 - 02/2000
3Hemorrhage
09/2014 - 05/2001
2Ischemia
10/2003 - 06/2001
2Hypoxia (Hypoxemia)
10/2001 - 06/2001
2Thrombocytopenia (Thrombopenia)
05/2001 - 11/2000
1Hypoglycemia (Reactive Hypoglycemia)
10/2001
1Atherosclerosis
09/2001
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2001
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2001
1Body Weight (Weight, Body)
06/2000
1Hyperglycemia
06/2000
1Hyperinsulinism (Hyperinsulinemia)
06/2000
1Insulin Resistance
06/2000
1Neuroblastoma
06/2000
1Dyslipidemias (Dyslipidemia)
06/2000
1Acute Coronary Syndrome
02/2000

Drug/Important Bio-Agent (IBA)

4Heparin (Liquaemin)FDA LinkGeneric
06/2004 - 11/2000
2AntithrombinsIBA
06/2004 - 09/2003
2ThrombinFDA Link
06/2004 - 09/2003
2Fondaparinux (Arixtra)FDA Link
06/2004 - 09/2003
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2002 - 02/2000
1Hemostatics (Antihemorrhagics)IBA
09/2014
1N- (6- (4- butanoyl- 5- methyl- 1H- pyrazol- 1- yl)pyridazin- 3- yl)- 5- chloro- 1- (2- (4- methylpiperazin- 1- yl)- 2- oxoethyl)- 1H- indole- 3- carboxamideIBA
09/2014
1Factor Xa (Coagulation Factor Xa)IBA
06/2004
1GABA-A Receptors (GABA(A) Receptor)IBA
10/2003
1ST 90 (ST90)IBA
09/2003
1Nadroparin (Nadroparin Calcium)IBA
10/2002
1Clopidogrel (Plavix)FDA Link
02/2002
1Adenosine Diphosphate (ADP)IBA
02/2002
1Oxygen (Dioxygen)IBA
10/2001
1Glucose (Dextrose)FDA LinkGeneric
10/2001
1IrbesartanFDA LinkGeneric
09/2001
1Angiotensin IIIBA
09/2001
1ApolipoproteinsIBA
09/2001
1Apolipoproteins E (ApoE)IBA
09/2001
1Neuropilin-1IBA
06/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2001
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2001
1SilkFDA Link
05/2001
1Thromboplastin (Tissue Factor)IBA
05/2001
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2001
1SR 123781AIBA
05/2001
1PyrinIBA
03/2001
1Dihydrotachysterol (AT 10)IBA
03/2001
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
03/2001
17- fluoro- 2- oxo- 4- (2- (4- (thieno(3,2- c)pyridin- 4- yl)piperazin- 1- yl)ethyl)- 1,2- dihydroquinoline- 1- acetamideIBA
03/2001
1acetamideIBA
03/2001
1Fc gamma receptor IIAIBA
11/2000
1Phospholipids (Phosphatides)FDA LinkGeneric
10/2000
1Factor Xa InhibitorsIBA
10/2000
1ThiazolidinedionesIBA
06/2000
1ciprofibrateIBA
06/2000
1SR 146131IBA
06/2000
1GW 9578IBA
06/2000
1Cholecystokinin (Pancreozymin)IBA
06/2000
1Peptides (Polypeptides)IBA
06/2000
1Fenofibrate (CiL)FDA LinkGeneric
06/2000
1SincalideFDA Link
06/2000
1Acetic Acid (Vinegar)FDA LinkGeneric
06/2000
1Cholecystokinin A ReceptorIBA
06/2000
1PPAR alphaIBA
06/2000
1Fibric Acids (Fibrates)IBA
06/2000
1SR 121566IBA
02/2000
1Platelet Membrane Glycoprotein IIbIBA
02/2000

Therapy/Procedure

1Oral Administration
09/2014
1Stents
02/2002
1Intravenous Administration
05/2001
1Therapeutics
02/2000